Literature DB >> 17092288

A matched-cohort comparison of laparoscopic cryoablation and laparoscopic partial nephrectomy for treating renal masses.

Rebecca L O'Malley1, Aaron D Berger, Jamie A Kanofsky, Courtney K Phillips, Michael Stifelman, Samir S Taneja.   

Abstract

OBJECTIVE: To compare the surgical outcomes of elderly patients with renal masses treated with laparoscopic partial nephrectomy (LPN) or laparoscopic cryoablation (LCA). PATIENTS AND METHODS: All 15 patients who had LCA at the authors' institution between May 2003 and July 2005 were included, and compared with a matched cohort of 15 patients selected by patient age and tumour size, from a pre-existing database of 104 patients who had LPN from July 2002 to July 2005. The two groups were compared for gender, number of comorbidities, American Society of Anesthesiologists status (ASA), body mass index (BMI), baseline renal function and haematocrit, location and size of lesion, length of stay, operative time, estimated blood loss (EBL), transfusion rate, number and type of complications, conversion rate, and postoperative renal function and haematocrit.
RESULTS: The two groups were similar in age, sex, BMI, ASA, baseline renal function, haematocrit, size and side of tumour, the percentage of exophytic tumours, and the likelihood of more than one comorbidity. Surgical outcomes between the groups were also relatively similar. The length of stay, creatinine and haematocrit levels after surgery did not differ between the groups. The LPN group had a significantly longer operation (248 vs 152 min, P < 0.001) and higher EBL (222 vs 59 mL, P = 0.007) than the LCA group, but only one patient required a transfusion and there was no discernible difference in discharge haematocrit values. No recurrences were detected in either group, with a similar mean follow-up of 9.8 and 11.9 months, respectively.
CONCLUSION: Although this matched-cohort comparison showed that LPN had a higher mean EBL, a longer operation and higher relative risk of open conversion, the overall clinical outcome was similar in terms of complication rates, length of stay and changes in creatinine and haematocrit after surgery. In this small retrospective evaluation, there was similar morbidity, treatment outcome and short-term efficacy with LCA and LPN. At present, although still experimental, LCA is a good choice for elderly patients with comorbidities precluding blood loss or renal ischaemia. However, in experienced hands, LPN is a preferred option for most elderly patients and should be considered when contemplating definitive treatment of renal masses.

Entities:  

Mesh:

Year:  2006        PMID: 17092288     DOI: 10.1111/j.1464-410X.2006.06554.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  16 in total

1.  Renal function and oncologic outcomes after cryoablation or partial nephrectomy for tumors in solitary kidneys.

Authors:  Jatinder Goyal; Abhinav Sidana; Christos S Georgiades; Ronald Rodriguez
Journal:  Korean J Urol       Date:  2011-06-17

2.  Ablative therapies for renal tumors.

Authors:  Rajan Ramanathan; Raymond J Leveillee
Journal:  Ther Adv Urol       Date:  2010-04

Review 3.  Systematic Review of Contemporary Evidence for the Management of T1 Renal Cell Carcinoma: What IRs Need to Know for Kidney Cancer Tumor Boards.

Authors:  Julie Cronan; Sean Dariushnia; Zachary Bercu; Robert Mitchell Ermentrout; Bill Majdalany; Laura Findeiss; Janice Newsome; Nima Kokabi
Journal:  Semin Intervent Radiol       Date:  2019-08-19       Impact factor: 1.513

4.  Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis.

Authors:  David A Kunkle; Robert G Uzzo
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

Review 5.  The impact of renal surgery on global renal function and non-oncologic morbidity.

Authors:  Elias S Hyams; William C Huang
Journal:  Curr Urol Rep       Date:  2009-01       Impact factor: 3.092

6.  Partial nephrectomy versus ablative techniques for small renal masses: a systematic review and network meta-analysis.

Authors:  Johannes Uhlig; Arne Strauss; Gerta Rücker; Ali Seif Amir Hosseini; Joachim Lotz; Lutz Trojan; Hyun S Kim; Annemarie Uhlig
Journal:  Eur Radiol       Date:  2018-09-25       Impact factor: 5.315

Review 7.  The contemporary role of ablative treatment approaches in the management of renal cell carcinoma (RCC): focus on radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), and cryoablation.

Authors:  Tobias Klatte; Nils Kroeger; Uwe Zimmermann; Martin Burchardt; Arie S Belldegrun; Allan J Pantuck
Journal:  World J Urol       Date:  2014-04-04       Impact factor: 4.226

8.  Saudi oncology society and Saudi urology association combined clinical management guidelines for renal cell carcinoma.

Authors:  Shouki Bazarbashi; Sultan Alkhateeb; Ashraf Abusamra; Danny Rabah; Mohammed Alotaibi; Mubarak Almansour; Esam Murshid; Abdullah Alsharm; Ashwaq Alolayan; Imran Ahmad; Khalid Alghamdi; Abdullah Alghamdi
Journal:  Urol Ann       Date:  2014-10

9.  Renal cryoablation of small renal masses: a Korea University experience.

Authors:  Hyung Keun Kim; Jong Hyun Pyun; Jae Yoon Kim; Seung Bin Kim; Seok Cho; Sung Gu Kang; Jeong Gu Lee; Je Jong Kim; Jun Cheon; Seok Ho Kang
Journal:  Korean J Urol       Date:  2015-02-02

10.  Laparoscopic Doppler technology in laparoscopic renal surgery.

Authors:  Mark A Perlmutter; Elias S Hyams; Michael D Stifelman
Journal:  JSLS       Date:  2009 Jul-Sep       Impact factor: 2.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.